Genomics-based characterization and personalized therapy of advanced thymic epithelial tumors

被引：0

作者：

Moehrmann, L. ^{[1
]}

Rostock, L. ^{[1
]}

Oles, M. ^{[2
,3
]}

Jahn, A. ^{[4
]}

Arlt, M. ^{[4
]}

Paramasivam, N. ^{[2
,3
]}

Joehrens, K. ^{[5
]}

Rupp, L. ^{[6
]}

Schmitz, M. ^{[6
]}

Richter, D. ^{[1
]}

Uhrig, S. ^{[2
,3
]}

Froehlich, M. ^{[2
,3
]}

Hutter, B. ^{[2
,3
]}

Huellein, J. ^{[2
,3
]}

Wolf, E. E. ^{[1
]}

Hanf, D. ^{[1
]}

Gieldon, L. ^{[7
]}

Kreutzfeldt, S. ^{[2
,8
]}

Heilig, C. E. ^{[2
,8
]}

Teleanu, V. ^{[2
,8
]}

Lipka, D. B. ^{[2
,8
]}

Mock, A. ^{[9
]}

Jelas, I. ^{[10
,11
]}

Rieke, D. T. ^{[10
,11
]}

Wiesweg, M. ^{[12
]}

Boerries, M. ^{[13
]}

Illert, A. L. ^{[14
]}

Desuki, A. ^{[15
]}

Kindler, T. ^{[15
]}

Krackhardt, A. M. ^{[16
]}

Westphalen, C. B. ^{[17
,18
]}

Grosch, H. ^{[19
]}

Apostolidis, L. ^{[2
,20
]}

Stenzinger, A. ^{[21
,22
]}

Kerle, I. A. ^{[1
]}

Horak, P. ^{[8
]}

Heining, C. ^{[1
]}

Huebschmann, D. ^{[2
,3
]}

Schroeck, E. ^{[4
]}

Froehling, S. ^{[2
,8
]}

Glimm, H. ^{[1
]}

机构：

[1] Natl Ctr Tumor Dis NCT UCC Dresden, Translat Med Oncol, Dresden, Germany

[2] NCT Heidelberg, Heidelberg, Germany

[3] German Canc Res Ctr, Computat Oncol Grp, Mol Precis Oncol Program, Heidelberg, Germany

[4] Tech Univ Dresden, Inst Clin Genet, Dresden, Germany

[5] Univ Hosp Carl Gustav Carus, Dept Pathol, Dresden, Germany

[6] Tech Univ Dresden, Inst Immunol, Fac Med Carl Gustav Carus, Dresden, Germany

[7] Carl von Ossietzky Univ Oldenburg, Inst Med Genet, Oldenburg, Germany

[8] DKFZ, Translat Med Oncol, Heidelberg, Germany

[9] Ludwig Maximilians Univ Munchen LMU, Inst Pathol, Munich, Germany

[10] Free Univ Berlin, Univ Med Berlin, Charite Comprehens Canc Ctr, Berlin, Germany

[11] Humboldt Univ, Berlin, Germany

[12] Univ Duisburg Essen, Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany

[13] Univ Freiburg, Inst Med Bioinformat & Syst Med, Med Ctr, Fac Med, Freiburg, Germany

[14] Univ Freiburg, Dept Internal Med 1, Med Ctr, Fac Med, Freiburg, Germany

[15] Univ Med Ctr Mainz, Univ Canc Ctr, Mainz, Germany

[16] TUM, Klinikum Rechts Isar, Sch Med, Klin & Poliklin Innere Med 3, Munich, Germany

[17] Ludwig Maximilians Univ Munchen, Univ Hosp, Munich, Germany

[18] Comprehens Canc Ctr, Dept Internal Med 3, Munich, Germany

[19] Univ Heidelberg Hosp, Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany

[20] Heidelberg Univ Hosp, Dept Med Oncol, Heidelberg, Germany

[21] Univ Hosp Heidelberg, Heidelberg, Germany

[22] Inst Pathol, Heidelberg, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V973

引用

页码：144 / 144

页数：1

共 50 条

[21] Induction therapy followed by surgery for advanced thymic tumors
Kao, Tzu-Ning
Yang, Pei-Wen
Lin, Mong-Wei
Lee, Jang-Ming
ASIAN JOURNAL OF SURGERY, 2020, 43 (06) : 707 - 708
[22] Platinum Rechallenge in Advanced Thymic Epithelial Tumors: Still an Option in the Age of Target Therapy? A Monocentric Experience
Ottaviano, M.
Damiano, V.
Perrone, P.
Capuano, M.
Tortora, M.
Forino, C.
Palmieri, G.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2065 - S2065
[23] Advanced Genomics-Based Approaches for Defining Allograft Rejection With Single Cell Resolution
Shi, Tiffany
Roskin, Krishna
Baker, Brian M.
Woodle, E. Steve
Hildeman, David
FRONTIERS IN IMMUNOLOGY, 2021, 12
[24] A population-based study of incidence, diagnostic approaches and therapy of thymic epithelial tumors
Schaapveld, M.
De Jong, W. K.
Timens, W.
Klinkenberg, T. J.
Blaauwgeers, J. L.
Groen, H. J.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[25] Impact of metastasis site for survival of patients with advanced thymic epithelial tumors
Cheng, Guoping
Gu, Cuipng
Song, Zhengbo
TRANSLATIONAL CANCER RESEARCH, 2016, 5 (05) : 546 - 551
[26] Emerging treatment options for patients with recurrent advanced thymic epithelial tumors
Evans, Tracey L.
ONCOTARGETS AND THERAPY, 2012, 5 : 177 - 184
[27] Impact of Metastasis Site for Survival of Patients with Advanced Thymic Epithelial Tumors
Yu, Xinmin
Song, Zhengbo
Zhang, Yiping
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1010 - S1010
[28] A novel genomics-based platform for the creation of synthetic promoters for cell and gene therapy
Iglesias, J. M.
Fraser, R. M.
Moran, S.
del Rio, P.
Baker, K.
Cooper, S.
Whyteside, G.
Braae, A.
Kippen, N.
Katsoupi, P.
Torrance, V.
Rajan, R.
Yanez, J. O.
Roberts, M. L.
HUMAN GENE THERAPY, 2018, 29 (12) : A166 - A166
[29] Clinical benefits of proton therapy in thymic epithelial tumors using a model-based approach
Peeters, S.
Kneepkens, E.
Marcuse, F.
Hochstenbag, M.
Maessen, J.
De Ruysscher, D.
RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1078 - S1080
[30] CAPECITABINE PLUS GEMCITABINE AS SECOND LINE THERAPY IN THYMIC EPITHELIAL TUMORS
Buonerba, Carlo
Damiano, Vincenzo
Ottaviano, Margaret
Federico, Piera
Calabrese, Filomena
Von Arx, Claudia
De Falco, Stefano
Candido, Ciro
De Maio, Ana Paula
Micillo, Mariateresa
Marino, Mirella
Palmieri, Giovannella
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (10) : S226 - S226

← 1 2 3 4 5 →